期刊
CANCER RESEARCH
卷 78, 期 12, 页码 3255-3266出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-17-2011
关键词
-
类别
资金
- JSPS KAKENHI [25293089, 16H05162, 16K09247, 16K10865]
- Grants-in-Aid for Scientific Research [16K09247, 16K10865, 17K08763, 16K15248, 25293089, 17H04060] Funding Source: KAKEN
Recent findings have shown the significance of CD163-positive macrophages in tumor progression, yet there have been few studies on the function of CD163 in macrophages. Here, we uncover the role of CD163 in macrophage activation using CD163-deficient mice and human samples. We detected Cl) 163 in 62 undifferentiated pleomorphic sarcoma samples, in which a high percentage of CD163 positive macrophages was associated with decreased overall survival and higher histologic grade. We observed macrophage-induced tumor cell proliferation in cocultures of human monocyte-derived macrophages and leiomyosarcoma (TYLMS-1) and myxofibrosarcoma (NMFH-1) cell lines, which was abrogated by silencing of CD163. Tumor development of sarcoma (MCA205 and WS) cells in CD163-deficient mice was significantly abrogated in comparison with wild-type (WT) mice. Coculture with WT peritoneal macrophages significantly increased proliferation of MCA205 cells but decreased in the presence of CD163-deficient macrophages. Production of IL6 and CXCL2 in CD163-defident macrophages was suppressed in comparison with WI-macrophages, and overexpression of CD163 in CD163-deficient macrophages induced production of IL6 and CXCL2. Silencing of IL6 but not CXCL2- abrogated macrophage-induced proliferation of MCA205 cells.Taken together, our results show that CD163 is involved in protumoral activation of macrophages and subsequent development and progression of tumors in mice and humans. Significance: Macrophage CD163-mediated induction of 11.6 promotes tumor development and progression in murine and human malignant tumors. (C)2018 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据